ArticleFASEB bioAdvances2026
Prediction of Risk of Unplanned Readmission or Death in Elderly Heart Failure Patients During the Vulnerable Phase: Machine Learning With SHAP Interpretation.
Article in FASEB bioAdvances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure (HF) as the final stage of cardiovascular disease in the elderly leads to frequent readmissions and seriously affects their quality of life. This study aimed to develop a predictive model for hospital readmission or death during the vulnerable phase in elderly HF patients, and to identify the key associated risk factors. The dataset was randomly divided into 70% training sets and 30% validation sets. Three feature selection methods were applied to the training data, followed by the construction of 18 predictive models using six machine learning (ML) algorithms (XGBoost, LightGBM, AdaBoost, GBDT, GNB, and SVM). The performance of each model was assessed on the validation set using receiver operating characteristic (ROC) curves, sensitivity, accuracy, specificity, F1 score, and Brier score. SHapley Additive exPlanations (SHAP) were used to interpret the feature contributions both globally and locally. Eleven models achieved an area under the ROC curve (AUC) greater than 0.8, with the Boruta-XGBoost model performing best, showing an AUC of 0.873 in the validation set, along with a sensitivity of 0.839, accuracy of 0.769, specificity of 0.747, F1 score of 0.634, and Brier score of 0.130. SHAP analysis revealed that the top five important features were hemoglobin (HGB), serum free thyroxine (FT4), age, diabetes, and serum potassium (K). The Boruta-XGBoost based risk prediction model, combined with SHAP interpretation, demonstrated high predictive accuracy and robust interpretability for forecasting hospital readmission or death during the vulnerable phase in elderly HF patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.